Flash Therapeutics
Latest round
- Series C
Last raised
- Sep 2023
Total raised
- $18M
Investors
- 3
About Flash Therapeutics
Founded in 2018 and based in Toulouse, France, Flash Therapeutics operates as a biotechnology company that offers gene therapy solutions. In May 2018, Vectalys SAS, a portfolio company of FJ Investissement, FaDiese, Galia Gestion, and Wiseed, merged with FlashCell, a portfolio company of Auriga Partners, to form Flash Therapeutics. Flash Therapeutics provides gene therapy solutions and develops DNA and RNA lentiviral technologies for a wide range of clients, including pharmaceutical companies and biotech startups. The products and solutions offered by the company include LentiFlash®, which is a biological RNA delivery technology that develops multiple RNA species based on a bacteriophage-lentivirus chimera, which allows for the efficient and safe delivery of RNA into a wide range of cell types; Lentiviral Vectors, a DNA delivery technology; Vectalys, a manufacturing platform that develops regenerative medicine for cancer treatments; TheraLymph program, a therapy to restore lymphatic flow lymphedema; immunotherapy solutions; cell therapy solutions; and many more.
Who invested in Flash Therapeutics
3 investors across 5 rounds
See all investors in Flash Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Flash Therapeutics
Who invested in Flash Therapeutics?
Flash Therapeutics has 3 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Flash Therapeutics raised?
Flash Therapeutics has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Flash Therapeutics last raise money?
Flash Therapeutics's most recent round on record is a Series C, in Sep 2023.
What does Flash Therapeutics do?
Founded in 2018 and based in Toulouse, France, Flash Therapeutics operates as a biotechnology company that offers gene therapy solutions.
Where is Flash Therapeutics headquartered?
Flash Therapeutics is headquartered in Toulouse, France.
Which VCs invest in companies like Flash Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Flash Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Flash Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.